Pharma executives predict increase in patent deal-making following US tax reform 12 Jan 18
A number of leading pharmaceuticals executives have said that recent US tax reforms will create a more conducive environment for patent transactions. Corroborating forecasts made by leading industry analysts suggest that 2018 will see a significant surge in this kind of deal-making in the life sciences sector.
Want to read more?
Register to access two of our subscriber-only articles per month
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts
What our customers are saying
IAM magazine is, in my opinion, the premier magazine in the space of managing intellectual assets for value creation. It brings a fresh, business-driven perspective, rather than a purely legal perspective, on this issue. I would highly recommend it to anyone dealing with how to manage and drive value from intellectual assets.
David A VandenEinde
Assistant vice president and intellectual asset management leader
Subscribe to receive access to the full range of premium business intelligence, insights and analysis, as well as our IP directories, guides and daily news.
Register for more free content
- Read more IAM blogs and articles
- Receive the editor's weekly review by email